Not so long ago, a series of studies lead by Dr. Rosenberg opened a new field by proposing to re-infuse in vitro expanded and IL-2-stimulated tumor-infiltrating lymphocytes to overcome immunotolerance in patients with metastatic melanoma and achieve tumour-control (1). Here, IL2 is linked to neoplasm.